Latest figures from the International Renewable Energy Agency find solar contributed the majority of a record 692 GW of ...

Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company advancing innovative small-molecule therapies in aesthetic medicine, metabolic diseases, and other unmet medical ...

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

Turbulence linked to the war in Iran and swings in valuations have yet to deter corporate deal-making as transactions in the ...

The issuer is solely responsible for the content of this announcement.

Renewable power made up almost 50% of the world’s electricity capacity last year after a record ‌increase in solar ...

IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer ...

CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...

Sagtec Global Limited (NASDAQ: SAGT), a rapidly emerging leader in autonomous enterprise and data infrastructure, today ...

A near-collapse of the global software vulnerability database exposed critical weaknesses that could leave banks unable to track cyber threats.

Data presented by Johnson & Johnson at the 2026 European Lung Cancer ConferencePARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) ...